Gary Sender Nabriva Therapeutics PLC (NBRV) insider trading activity

Gary Sender is Chief Financial Officer of Nabriva Therapeutics plc. Currently has a direct ownership of 20,472 shares of NBRV, which is worth approximately $8,188. The most recent transaction as insider was on Feb 28, 2021, when has been sold 31 shares (Ordinary Shares) at a price of $2.39 per share, resulting in proceeds of $74. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.5K

0% 3M change

0% 12M change

Total Value Held $8,188

Gary Sender Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2021	SELL Payment of exercise price or tax liability	$74 $2.39 p/Share	31 Reduced 0.15%	20,472 Ordinary Shares
Jan 31 2021	SELL Payment of exercise price or tax liability	$97 $2.62 p/Share	37 Reduced 0.18%	20,503 Ordinary Shares
Dec 31 2020	SELL Payment of exercise price or tax liability	$77 $2.42 p/Share	32 Reduced 0.16%	20,540 Ordinary Shares
Nov 30 2020	SELL Payment of exercise price or tax liability	$134 $0.43 p/Share	312 Reduced 0.15%	205,728 Ordinary Shares
Oct 31 2020	SELL Payment of exercise price or tax liability	$156 $0.5 p/Share	312 Reduced 0.15%	206,040 Ordinary Shares
Sep 30 2020	SELL Payment of exercise price or tax liability	$165 $0.53 p/Share	312 Reduced 0.15%	206,352 Ordinary Shares

Also insider at

IBIO

iBio, Inc. Healthcare

Director

SDGR

Schrodinger, Inc. Healthcare

Director

HRMY

Harmony Biosciences Holdings, Inc. Healthcare

Gary Sender

Chief Financial Officer

Plymouth Meeting, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account